XIORF(XIORF)
XIORF
No analyst ratings available
No analyst price targets available for XIORF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $223M | $237M | $247M | $254M |
| Low | $217M | $226M | $238M | $245M |
| High | $227M | $245M | $254M | $261M |
| EBITDA Avg | $87M | $92M | $96M | $99M |
| Low | $85M | $88M | $93M | $96M |
| High | $88M | $95M | $99M | $102M |
| EBIT Avg | $86M | $92M | $96M | $99M |
| Low | $84M | $88M | $92M | $95M |
| High | $88M | $95M | $98M | $101M |
| Net Income Avg | $143M | $150M | $154M | $160M |
| Low | $137M | $143M | $147M | $152M |
| High | $148M | $155M | $159M | $165M |
| EPS Avg | $2.62 | $2.74 | $2.81 | $2.92 |
| Low | $2.50 | $2.61 | $2.68 | $2.78 |
| High | $2.71 | $2.83 | $2.91 | $3.02 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 6 / 1 | 7 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q3 2028 |
|---|---|---|---|
| Revenue Avg | $63M | $23M | $56M |
| Low | $63M | $23M | $56M |
| High | $63M | $23M | $56M |
| EBITDA Avg | $24M | $9M | $22M |
| Low | $24M | $9M | $22M |
| High | $24M | $9M | $22M |
| EBIT Avg | $24M | $9M | $22M |
| Low | $24M | $9M | $22M |
| High | $24M | $9M | $22M |
| Net Income Avg | $76M | $37M | $36M |
| Low | $76M | $37M | $36M |
| High | $76M | $37M | $36M |
| EPS Avg | $1.41 | $0.69 | $0.66 |
| Low | $1.41 | $0.69 | $0.66 |
| High | $1.41 | $0.69 | $0.66 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |